Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Tiago M. de Carvalho"'
Autor:
Partha Basu, Rengaswamy Sankaranarayanan, Ishu Kataria, Johannes Berkhof, Eric Lucas, Lopamudra Ray Saraswati, Iacopo Baussano, Richard Muwonge, Johannes A Bogaards, Tiago M de Carvalho, Irene Man, Damien Georges, Prince Bhandari, Mariam Siddiqui
Publikováno v:
BMJ Global Health, Vol 8, Iss 11 (2023)
Background Cervical cancer is a major public health problem in India, where access to prevention programmes is low. The WHO-Strategic Advisory Group of Experts recently updated their recommendation for human papillomavirus (HPV) vaccination to includ
Externí odkaz:
https://doaj.org/article/2ed21aa7ad664d4086bb34c6a82af48c
Autor:
Irene Man, Damien Georges, Tiago M de Carvalho, Lopamudra Ray Saraswati, Prince Bhandari, Ishu Kataria, Mariam Siddiqui, Richard Muwonge, Eric Lucas, Johannes Berkhof, Rengaswamy Sankaranarayanan, Johannes A Bogaards, Partha Basu, Iacopo Baussano
Publikováno v:
Man, I, Georges, D, de Carvalho, T M, Ray Saraswati, L, Bhandari, P, Kataria, I, Siddiqui, M, Muwonge, R, Lucas, E, Berkhof, J, Sankaranarayanan, R, Bogaards, J A, Basu, P & Baussano, I 2022, ' Evidence-based impact projections of single-dose human papillomavirus vaccination in India : a modelling study ', Lancet Oncology, vol. 23, no. 11, pp. 1419-1429 . https://doi.org/10.1016/S1470-2045(22)00543-5
Lancet Oncology, 23(11), 1419-1429. Lancet Publishing Group
Lancet Oncology, 23(11), 1419-1429. Lancet Publishing Group
BACKGROUND: Despite the high burden of cervical cancer, access to preventive measures remains low in India. A single-dose immunisation schedule could facilitate the scale-up of human papillomavirus (HPV) vaccination, contributing to global eliminatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3aaddfea6bc34c5807666ca2cdd21332
https://doi.org/10.1016/s1470-2045(22)00543-5
https://doi.org/10.1016/s1470-2045(22)00543-5
Autor:
Veerle M.H. Coupé, Hendrik Koffijberg, Joost van Rosmalen, Harold B. Wolff, Tiago M. de Carvalho
Publikováno v:
de Carvalho, T M, van Rosmalen, J, Wolff, H B, Koffijberg, H & Coupé, V M H 2022, ' Choosing a Metamodel of a Simulation Model for Uncertainty Quantification ', Medical Decision Making, vol. 42, no. 1, pp. 28-42 . https://doi.org/10.1177/0272989X211016307
Medical Decision Making, 42(1), 28-42. SAGE Publications Inc.
Medical Decision Making, 42(1), 28-42. SAGE Publishing
Medical decision making, 42(1), 28-42. SAGE Publications
Medical Decision Making, 42(1), 28-42. SAGE Publications Inc.
Medical Decision Making, 42(1), 28-42. SAGE Publishing
Medical decision making, 42(1), 28-42. SAGE Publications
Background Metamodeling may substantially reduce the computational expense of individual-level state transition simulation models (IL-STM) for calibration, uncertainty quantification, and health policy evaluation. However, because of the lack of guid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::856883832edeaf51e18f7bc7706e3a53
https://research.vumc.nl/en/publications/67ddc060-0fdd-4879-9660-f726d0c30c24
https://research.vumc.nl/en/publications/67ddc060-0fdd-4879-9660-f726d0c30c24
Publikováno v:
Cancer. 124:507-513
BACKGROUND Because of the recent grade C draft recommendation by the US Preventive Services Task Force (USPSTF) for prostate cancer screening between the ages of 55 and 69 years, there is a need to determine whether this could be cost-effective in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9848994f8637b8bbec958ddf686233ed
https://doi.org/10.1002/cncr.31141
https://doi.org/10.1002/cncr.31141
Autor:
Eric J. Feuer, Eveline A.M. Heijnsdijk, Paul F. Pinsky, Ruth Etzioni, Jonas Hugosson, Vera Nelen, Arnauld Villers, Marco Zappa, Alexander Tsodikov, Roman Gulati, Tiago M. de Carvalho, Maciej Kwiatkowski, E. David Crawford, Harry J. de Koning, Marcos Lujan, Christine D. Berg, Anssi Auvinen, Sue Moss, Monique J. Roobol, Angela B. Mariotto, Gerald L. Andriole
Publikováno v:
Cancer. 124:1197-1206
Background The European Randomized Study of Screening for Prostate Cancer (ERSPC) demonstrated that prostate-specific antigen (PSA) screening significantly reduced prostate cancer mortality (rate ratio, 0.79; 95% confidence interval, 0.69-0.91). The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e1a7799c7bfba0bcb0b9f7503cd95d75
https://doi.org/10.1002/cncr.31178
https://doi.org/10.1002/cncr.31178
Autor:
Martin Eklund, Harry J. de Koning, Vera Nelen, Markus Graefen, Xavier Castells, Chris H. Bangma, Henrik Grönberg, Josep A. Espinàs, Franz Recker, Eveline A.M. Heijnsdijk, Iris Lansdorp-Vogelaar, Tiago M. de Carvalho, Pieter Vandenbulcke, Josep M. Borràs, Monique J. Roobol, Pim J. van Leeuwen
Publikováno v:
International Journal of Cancer. 142:741-746
The European Randomised Study of Screening for Prostate Cancer (ERSPC) showed that Prostate-Specific Antigen (PSA) based screening results in a significant prostate cancer mortality reduction. Although there are concerns on overdiagnosis and overtrea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21aeb8f933425c5e9221c7148c15ad38
https://doi.org/10.1002/ijc.31102
https://doi.org/10.1002/ijc.31102
Autor:
Alexander Tsodikov, Harry J. de Koning, Tiago M. de Carvalho, Roman Gulati, Eveline A.M. Heijnsdijk, Ruth Etzioni, Angela B. Mariotto, Rachel Hunter-Merrill
Publikováno v:
Cancer. 123:2312-2319
BACKGROUND: Black men in the United States have substantially higher prostate cancer incidence rates than the general population. The extent to which this incidence disparity is because prostate cancer is more prevalent, more aggressive, and/or more
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d8d1ee343f32ca9532d957ea83cc1e4
https://doi.org/10.1002/cncr.30687
https://doi.org/10.1002/cncr.30687
Publikováno v:
Prostate, 77(9), 962-969. Wiley-Liss Inc.
BACKGROUND: A significant proportion of screen-detected men with prostate cancer may be overdiagnosed. Active Surveillance (AS) has emerged as a way to mitigate this problem, by delaying treatment of men, who are at low-risk until this becomes necess
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::660acd00faa91eb5795869809b201807
https://doi.org/10.1002/pros.23352
https://doi.org/10.1002/pros.23352
Publikováno v:
Medical Decision Making, 39(4), 405-413. SAGE Publishing
Med Decis Making
Med Decis Making
Background. Microsimulation models have been extensively used in the field of cancer modeling. However, there is substantial uncertainty regarding estimates from these models, for example, overdiagnosis in prostate cancer. This is usually not thoroug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89bb7defb990b906571dbc3a04ae12d8
https://pubmed.ncbi.nlm.nih.gov/31804156
https://pubmed.ncbi.nlm.nih.gov/31804156
Autor:
Sigrid Carlsson, Vera Nelen, Monique J. Roobol, Eveline A.M. Heijnsdijk, Marco Zappa, Andrew J. Vickers, Jonas Hugosson, Harry J. de Koning, Arnauld Villers, Alvaro Paez, Anssi Auvinen, Maciej Kwiatkowski, Hans Lilja, Tiago M. de Carvalho, James A. Eastham
Publikováno v:
Cancer. 122:3386-3393
BACKGROUND: Prostate-specific antigen (PSA) screening and concomitant treatment can be implemented in several ways. The authors investigated how the net benefit of PSA screening varies between common practice versus “good practice.”. METHODS: Mic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a79cf331e16319bbfefa3b1442767b88
https://doi.org/10.1002/cncr.30192
https://doi.org/10.1002/cncr.30192